Rational stepwise approach for Mycoplasma pneumoniae pneumonia in children.
Tsai TA, Tsai CK, Kuo KC, Yu HR.
J Microbiol Immunol Infect. 2021 Aug;54(4):557-565. doi: 10.1016/j.jmii.2020.10.002. Epub 2020 Oct 17.
Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children.
Lee H, Yun KW, Lee HJ, Choi EH.
Expert Rev Anti Infect Ther. 2018 Jan;16(1):23-34. doi: 10.1080/14787210.2018.1414599. Epub 2017 Dec 11.
Chest imaging classification in Mycoplasma pneumoniae pneumonia is associated with its clinical features and outcomes.
Huang X, Gu H, Wu R, Chen L, Lv T, Jiang X, Li H, Guo B, Liu J, Li D, Zhao D, Liu F.
Respir Med. 2024 Jan;221:107480. doi: 10.1016/j.rmed.2023.107480. Epub 2023 Dec 1.
Mycoplasma pneumoniae.
Paquette M, Magyar M, Renaud C.
CMAJ. 2024 Sep 30;196(32):E1120. doi: 10.1503/cmaj.240085.
Mycoplasma Pneumonia in Children and Adolescents.
Krafft C, Christy C.
Pediatr Rev. 2020 Jan;41(1):12-19. doi: 10.1542/pir.2018-0016.
Mycoplasma pneumoniae pneumonia.
Mansel JK, Rosenow EC 3rd, Smith TF, Martin JW Jr.
Chest. 1989 Mar;95(3):639-46. doi: 10.1378/chest.95.3.639.
Neutrophil-to-lymphocyte ratio as a predictor of poor outcomes of Mycoplasma pneumoniae pneumonia.
Li D, Gu H, Chen L, Wu R, Jiang Y, Huang X, Zhao D, Liu F.
Front Immunol. 2023 Dec 19;14:1302702. doi: 10.3389/fimmu.2023.1302702. eCollection 2023.
Mycoplasma pneumoniae and its role as a human pathogen.
Waites KB, Talkington DF.
Clin Microbiol Rev. 2004 Oct;17(4):697-728, table of contents. doi: 10.1128/CMR.17.4.697-728.2004.
Laboratory diagnosis and treatment of Mycoplasma pneumoniae infection in children: a review.
Gao L, Sun Y.
Ann Med. 2024 Dec;56(1):2386636. doi: 10.1080/07853890.2024.2386636. Epub 2024 Aug 3.
Clinical features and "early" corticosteroid treatment outcome of pediatric mycoplasma pneumoniae pneumonia.
Liu J, He R, Zhang X, Zhao F, Liu L, Wang H, Zhao S.
Front Cell Infect Microbiol. 2023 Apr 4;13:1135228. doi: 10.3389/fcimb.2023.1135228. eCollection 2023.
